| FASMX | RLBBX | FASMX / RLBBX | |
| Total Expense Ratio | 0.53 | 1.32 | 40% |
| Annual Report Gross Expense Ratio | 0.56 | 1.32 | 42% |
| Fund Existence | 37 years | 24 years | - |
| Gain YTD | 2.612 | 2.396 | 109% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.6B | 270B | 4% |
| Annual Yield % from dividends | 2.31 | 1.23 | 188% |
| Returns for 1 year | 10.51 | 10.49 | 100% |
| Returns for 3 years | 28.30 | 33.68 | 84% |
| Returns for 5 years | 17.37 | 31.41 | 55% |
| Returns for 10 years | 71.06 | 79.44 | 89% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HRMDX | 14.24 | 0.21 | +1.50% |
| Heartland Mid Cap Value Investor | |||
| BDSCX | 20.22 | 0.04 | +0.20% |
| BlackRock Advantage Small Cap Core Inv C | |||
| RYOIX | 77.25 | -0.11 | -0.14% |
| Rydex Biotechnology Inv | |||
| VRTGX | 471.00 | -1.06 | -0.22% |
| Vanguard Russell 2000 Growth Index I | |||
| RFNGX | 94.71 | -1.14 | -1.19% |
| American Funds Fundamental Invs R6 | |||